In an interview with Christine Moutier, MD, psychiatrist and chief medical officer of the American Foundation for Suicide Prevention, she speaks about how the current COVID-19 pandemic presents opportunities to improve suicide prevention efforts on multiple levels.
Researchers conducted a population-based, longitudinal cohort study of data from adolescent participants in the IMAGEN Study, seeking to identify early associations with the development of eating disorders.
Researchers compared the rate at which patients diagnosed with both depression and a substance use disorder received acute and continuous pharmacotherapy and psychotherapy with the rate at which patients solely diagnosed with depression received the same treatments.
Excessive stress because of the COVID-19 pandemic can have a detrimental effect on nurses’ mental health; therefore, the APNA has developed a Well-Being Initiative for nurses seeking help for excessive stress.
Adherence to antidepressants, rather than the adequacy of the prescribed antidepressant dosage, is predictive of treatment response in middle-aged and older patients who are being treated for depression in primary care.
Researchers conducted an 8-week, open-label, single-arm study and a subsequent 2-stage, sequential, parallel comparison study to assess the use of pimavanserin among patients with Parkinson disease and major depressive disorder.